UK markets open in 5 hours 42 minutes
NIKKEI 225
38,189.73 -39.38 (-0.10%) HANG SENG
18,963.68 0.00 (0.00%) CRUDE OIL
77.96 -0.30 (-0.38%) GOLD FUTURES
2,368.80 -6.20 (-0.26%) DOW
39,512.84 +125.04 (+0.32%) Bitcoin GBP
49,025.21 +307.28 (+0.63%)
IDEAYA Biosciences, Inc. (30J.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:04AM CEST
| Previous close | 37.80 |
| Open | 37.20 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 37.20 - 37.20 |
| 52-week range | 18.90 - 44.40 |
| Volume | |
| Avg. volume | 19 |
| Market cap | 2.891B |
| Beta (5Y monthly) | 0.82 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.86 |
| Earnings date | 08 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 30.44 |
Simply Wall St.IDEAYA Biosciences First Quarter 2024 Earnings: US$0.53 loss per share (vs US$0.49 loss in 1Q 2023)
IDEAYA Biosciences ( NASDAQ:IDYA ) First Quarter 2024 Results Key Financial Results Net loss: US$39.6m (loss widened by...
- GuruFocus.com
IDEAYA Biosciences Inc (IDYA) Reports Q1 2024 Earnings: Financial and Strategic Developments
Comparative Analysis of Q1 Earnings Against Analyst Expectations and Future Projections
PR NewswireIDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, provided a business update, and announced financial results for the first quarter ended March 31, 2024.
© 2024 Yahoo. All rights reserved.